Larry Herrera

536 total citations
13 papers, 415 citations indexed

About

Larry Herrera is a scholar working on Molecular Biology, Immunology and Neurology. According to data from OpenAlex, Larry Herrera has authored 13 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Neurology. Recurrent topics in Larry Herrera's work include Toxin Mechanisms and Immunotoxins (5 papers), Cancer therapeutics and mechanisms (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Larry Herrera is often cited by papers focused on Toxin Mechanisms and Immunotoxins (5 papers), Cancer therapeutics and mechanisms (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Larry Herrera collaborates with scholars based in United States, Poland and Germany. Larry Herrera's co-authors include Eric Sandler, Ellen S. Vitetta, George R. Buchanan, Roula Farah, Victor Gheţie, Deborah B. Aquino, Victor M. Aquino, Birgitta Clinchy, E S Vitetta and Paul G. Schlegel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Larry Herrera

13 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry Herrera United States 10 167 125 106 104 85 13 415
M Konrad Austria 7 64 0.4× 115 0.9× 45 0.4× 68 0.7× 141 1.7× 8 346
Geoffrey A. Smith United States 9 141 0.8× 207 1.7× 22 0.2× 106 1.0× 57 0.7× 9 445
Emily Walker United States 6 135 0.8× 156 1.2× 17 0.2× 162 1.6× 86 1.0× 11 418
GF Hollis United States 6 87 0.5× 150 1.2× 110 1.0× 227 2.2× 141 1.7× 8 452
Joaquina Mascarenhas United States 3 71 0.4× 78 0.6× 31 0.3× 237 2.3× 39 0.5× 3 322
Nicholas A. Zorko United States 11 165 1.0× 176 1.4× 28 0.3× 104 1.0× 78 0.9× 31 470
Ameera Alsadeq Germany 7 68 0.4× 114 0.9× 27 0.3× 62 0.6× 63 0.7× 16 264
Lüder Hinrich Meyer Germany 10 116 0.7× 44 0.4× 8 0.1× 181 1.7× 144 1.7× 24 381
Natalie Donin Israel 9 71 0.4× 197 1.6× 54 0.5× 148 1.4× 30 0.4× 21 351
Floris D. de Hon Netherlands 6 154 0.9× 146 1.2× 76 0.7× 87 0.8× 17 0.2× 10 365

Countries citing papers authored by Larry Herrera

Since Specialization
Citations

This map shows the geographic impact of Larry Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Herrera more than expected).

Fields of papers citing papers by Larry Herrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Herrera. The network helps show where Larry Herrera may publish in the future.

Co-authorship network of co-authors of Larry Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Herrera. A scholar is included among the top collaborators of Larry Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Herrera. Larry Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Herrera, Larry, et al.. (2016). P-017 Analysis of microRNA expression in Gastroenteropancreatic Neuroendocrine Tumor. Annals of Oncology. 27. ii5–ii5. 1 indexed citations
2.
Herrera, Larry, Bruce Bostrom, Eric Sandler, et al.. (2009). A Phase 1 Study of Combotox in Pediatric Patients With Refractory B-lineage Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 31(12). 936–941. 73 indexed citations
3.
Stokłosa, Tomasz, Tomasz Popławski, Mateusz Koptyra, et al.. (2008). BCR/ABL Inhibits Mismatch Repair to Protect from Apoptosis and Induce Point Mutations. Cancer Research. 68(8). 2576–2580. 65 indexed citations
4.
Herrera, Larry, et al.. (2007). Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines. Leukemia Research. 32(4). 625–632. 17 indexed citations
5.
Herrera, Larry, et al.. (2006). Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia. Leukemia & lymphoma. 47(11). 2380–2387. 13 indexed citations
6.
Morgan, David, et al.. (2005). The anti-CD19 immunotoxin (HD37-dgRTA) is more effective when combined with chemotherapy. Cancer Research. 65. 162–162. 2 indexed citations
7.
Herrera, Larry, et al.. (2003). Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins. Leukemia. 17(2). 334–338. 39 indexed citations
8.
Herrera, Larry, et al.. (2000). Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro. Leukemia. 14(5). 853–858. 57 indexed citations
9.
Aquino, Victor M., Larry Herrera, Eric Sandler, & George R. Buchanan. (2000). Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer. 88(7). 1710–1714. 1 indexed citations
10.
Herrera, Larry. (2000). Kant on the Moral Triebfeder. Kant-Studien. 91(4). 395–410. 15 indexed citations
11.
Mantadakis, Elpis, Larry Herrera, Patrick J. Leavey, et al.. (2000). Fractionated Cyclophosphamide and Etoposide for Children With Advanced or Refractory Solid Tumors: A Phase II Window Study. Journal of Clinical Oncology. 18(13). 2576–2581. 11 indexed citations
12.
Aquino, Victor M., Larry Herrera, Eric Sandler, & George R. Buchanan. (2000). Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer. 88(7). 1710–1714. 60 indexed citations
13.
Farah, Roula, Birgitta Clinchy, Larry Herrera, & Ellen S. Vitetta. (1998). The Development of Monoclonal Antibodies for the Therapy of Cancer. Critical Reviews in Eukaryotic Gene Expression. 8(3-4). 321–356. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026